Tumor Microenvironment

Blocking indolamine 2,3 dioxygenase mediated rebound immune suppression improves systemic anti-tumor effects of radio-immunotherapy
Arta M Monjazeb, Michael Kent, Steven K Grossenbacher, William Murphy

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P368; DOI: 10.1186/2051-1426-3-S2-P368
Genome editing of tumor specific T cells for sustained functionality in a suppressive tumor microenvironment
Sara R Pedersen, Per Thor Straten

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P43; DOI: 10.1186/2051-1426-3-S2-P43
Variable density of CD8+ and CD25+ programmed cell death-1 (PD-1) ligand (PD-L1) CD4+ T cells within the tumor microenvironment causes differential responses to the PD-1/PD-L1 blockade
Si-Pei Wu, Yi-Long Wu

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P423; DOI: 10.1186/2051-1426-3-S2-P423
Generation and utilization of polyfunctional anti-tumor CD4+ T cells
Gang Zhou, Zhi-Chun Ding

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P63; DOI: 10.1186/2051-1426-3-S2-P63
A new paradigm for tumor immune escape: β-catenin-driven immune exclusion
Stefani Spranger, Thomas F. Gajewski

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 43; DOI: 10.1186/s40425-015-0089-6
Foxp3 expression in breast cancer patient from Qatar: survival analysis
Mahmoud G Mohamed, Hina Sarwath, Shaykha Alqahtani, Salha Bujjasoum, Imad Bin Mujeeb, Mufeed Almesteri, Hikmat Bugrein, Prem Chandra, Shahinaz Bedri

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 1) O2; DOI: 10.1186/2051-1426-3-S1-O2
New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy
Gang Guo, Yan Cui

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 9; DOI: 10.1186/s40425-015-0053-5
Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction
Ravikumar Muthuswamy, Liwen Wang, Jamie Pitteroff, Jeffrey R Gingrich, Pawel Kalinski

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 6; DOI: 10.1186/s40425-015-0050-8
Expression of indoleamine 2.3-dioxygenase by tumors induces local and systemic immunosuppressive effects in a murine melanoma model
Rikke B Holmgaard, Dmitriy Zamarin, David H Munn, Taha Merghoub, Jedd D Wolchok

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P212; DOI: 10.1186/2051-1426-2-S3-P212
Validation and clinical correlation of triplex CD3, CD8 and FOXP3 IHC of tumor-infiltrating lymphocytes in follicular lymphoma
James Mansfield, Christian Slater, Richard Byers

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P261; DOI: 10.1186/2051-1426-2-S3-P261

Main menu

Tumor Microenvironment

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Tumor Microenvironment

Pages